Skip to main content

Critics Lead Gilead to Drop Coronavirus Drug Status

photo of virus coronavirus headline text

Gilead asked the U.S. Food and Drug Administration to designate remdesivir a so-called orphan drug, saying it qualified as a rare disease because fewer than 200,000 Americans are infected with the coronavirus.



from WebMD Health https://ift.tt/2xrxTUZ
via IFTTT

Comments

Popular posts from this blog

The Future of Autoimmune Disorders: Psoriatic Disease

What's being done to help people with psoriatic disease? We get a look at the ever-changing picture from a rheumatologist. from WebMD Health https://ift.tt/5P6ZHyd via IFTTT

Long COVID Experts: ‘So Incredibly Clear What’s at Stake’

It’s estimated that more than a third of people who have had COVID-19 experience neurological complications such as brain fog that persist or develop 3 months after infection. And two thirds of so-called long haulers still have neurological symptoms after 6 months. from WebMD Health https://ift.tt/mx1j6QD via IFTTT

Study: Black Men Twice as Likely to Develop Prostate Cancer as Whites

A review of men seen at VA hospitals found that Black veterans had nearly twice the incidence of localized and advanced prostate cancer as white men. from WebMD Health https://ift.tt/3Knscs2 via IFTTT